Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val158 Met polymorphism in adults with 22q11 deletion syndrome

Journal of Psychopharmacology

Volumn 26, Issue 12, 2012, Pages 1548-1560

  De Koning, Mariken B ^a,b   Boot, Erik ^a,c   Bloemen, Oswald J N ^a   Van Duin, Esther D A ^a,d   Abel, Kathryn M ^e   De Haan, Lieuwe ^a   Linszen, Don H ^a   Van Amelsvoort, Thérèse A M J ^a,f  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Arkin Mental Health Care   (Netherlands)

^c Ipse de Bruggen   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

22q11 deletion syndrome; COMT; Dopamine; prepulse inhibition; startle reactivity; velo cardio facial syndrome

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; PROLACTIN; VALINE;

ACOUSTIC REFLEX; ADULT; ARTICLE; AUDITORY STIMULATION; CHROMOSOME DELETION 22Q11; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEMIZYGOTE; HUMAN; MALE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SMOKING; STARTLE REFLEX;

22Q11 DELETION SYNDROME; ACOUSTIC STIMULATION; ADULT; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; FEMALE; GENOTYPE; HEMIZYGOTE; HUMANS; MALE; POLYMORPHISM, GENETIC; PREFRONTAL CORTEX; STARTLE REACTION; YOUNG ADULT;

EID: 84870455410     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112456610     Document Type: Article

References (94)

1. Abel KM, Allin MP, Hemsley DR, et al. Low dose ketamine increases prepulse inhibition in healthy men. Neuropharmacology. 2003 ; 44: 729-737
2. Abel KM, Allin M, Van Amelsvoort T, et al. The indirect serotonergic agonist d-fenfluramine and prepulse inhibition in healthy men. Neuropharmacology. 2007 ; 52: 1088-1094
3. Abel KM, Jolley S, Hemsley DR, et al. The influence of schizotypy traits on prepulse inhibition in young healthy controls. J Psychopharmacol. 2004 ; 18: 181-188
4. Abel K, Waikar M, Pedro B, et al. Repeated testing of prepulse inhibition and habituation of the startle reflex: A study in healthy human controls. J Psychopharmacol. 1998 ; 12: 330-337
5. Abi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol. 2004 ; 7: S1 - S5
6. Diagnostic and Statistical Manual of Mental Disorders. 1994 ) Diagnostic and Statistical Manual of Mental Disorders, 4th ed.Washington, DC: American Psychiatric Press. Washington, DC: American Psychiatric Press ; 1994 :
7. Antshel KM, Fremont W, Roizen NJ, et al. ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry. 2006 ; 45: 596-603
8. Antshel KM, Kates WR, Roizen N, et al. 22q11.2 deletion syndrome: genetics, neuroanatomy and cognitive/behavioral features keywords. Child Neuropsychol. 2005 ; 11: 5-19
9. Arnold PD, Siegel-Bartelt J, Cytrynbaum C, et al. Velo-cardio-facial syndrome: Implications of microdeletion 22q11 for schizophrenia and mood disorders. Am J Med Genet. 2001 ; 105: 354-362
10. Aukes MF, Alizadeh BZ, Sitskoorn MM, et al. Genetic overlap among intelligence and other candidate endophenotypes for schizophrenia. Biol Psychiatry. 2009 ; 65: 527-534
11. Baker KD, Skuse DH. Adolescents and young adults with 22q11 deletion syndrome: Psychopathology in an at-risk group. Br J Psychiatry. 2005 ; 186: 115-120
12. Bassett AS, Chow EW, Husted J, et al. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A. 2005 ; 138: 307-313
13. Bitsios P, Giakoumaki SG, Frangou S. The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values. Psychopharmacology (Berl). 2005 ; 182: 144-152
14. Boot E, Booij J, Abeling N, et al. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia - relationship with COMT Val108/158Met polymorphism, gender and symptomatology. J Psychopharmacol. 2011a ; 25: 888-895
15. Boot E, Booij J, Zinkstok J, et al. Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome. Neuropsychopharmacology. 2008 ; 33: 1252-1258
16. Boot E, Booij J, Zinkstok JR, et al. COMT Val158Met genotype and striatal D2/3 receptor binding in adults with 22q11 deletion syndrome. Synapse. 2011b ; 65: 967-970
17. Boot E, Booij J, Zinkstok JR, et al. Striatal D2 receptor binding in 22q11 deletion syndrome: An [123I]IBZM SPECT study. J Psychopharmacol. 2010 ; 24: 1525-1531
18. Botto LD, May K, Fernhoff PM, et al. A population-based study of the 22q11.2 deletion: Phenotype, incidence, and contribution to major birth defects in the population. Pediatrics. 2003 ; 112: 101-107
19. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001 ; 156: 234-258
20. Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 1992 ; 49: 206-215
21. Braff D, Stone C, Callaway E, et al. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 1978 ; 15: 339-343
22. Broersen LM, Feldon J, Weiner I. Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion. Neuroscience. 1999 ; 94: 39-46
23. Canavan A, Dunn G, McMillan TM. Principal components of the WAIS-R. Br J Clin Psychol. 1986 ; 25: 81-85
24. Chen J, Lipska BK, Halim N, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 2004 ; 75: 807-821
25. Csomor PA, Stadler RR, Feldon J, et al. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology. 2008a ; 33: 497-512
26. Csomor PA, Yee BK, Vollenweider FX, et al. On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behav Neurosci. 2008b ; 122: 885-900
27. Drew LJ, Crabtree GW, Markx S, et al. The 22q11.2 microdeletion: Fifteen years of insights into the genetic and neural complexity of psychiatric disorders. Int J Dev Neurosci. 2011 ; 29: 259-281
28. Edelmann L, Pandita RK, Spiteri E, et al. A common molecular basis for rearrangement disorders on chromosome 22q11. Hum Mol Genet. 1999 ; 8: 1157-1167
29. Fine SE, Weissman A, Gerdes M, et al. Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disord. 2005 ; 35: 461-470
30. Geyer MA, Krebs-Thomson K, Braff DL, et al. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology (Berl). 2001 ; 156: 117-154
31. Giakoumaki SG, Roussos P, Bitsios P. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Neuropsychopharmacology. 2008 ; 33: 3058-3068
32. Goldman-Rakic PS, Muly EC, Williams GV. D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev. 2000 ; 31: 295-301
33. Gothelf D, Eliez S, Thompson T, et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci. 2005 ; 8: 1500-1502
34. Gothelf D, Presburger G, Zohar AH, et al. Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am J Med Genet B Neuropsychiatr Genet. 2004 ; 126B: 99-105
35. Gothelf D, Schaer M, Eliez S. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Dev Disabil Res Rev. 2008 ; 14: 59-68
36. Greenwood TA, Lazzeroni LC, Murray SS, et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2011 ; 168: 930-946
37. Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management. Drugs. 2004 ; 64: 2291-2314
38. Hirvonen MM, Nagren K, Rinne JO, et al. COMT Val158Met genotype does not alter cortical or striatal dopamine D2 receptor availability in vivo. Mol Imaging Biol. 2010 ; 12: 192-197
39. Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 2009 ; 66: 13-20
40. Hutchison KE, Swift R. Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology (Berl). 1999 ; 143: 394-400
41. Kane JM, Leucht S, Carpenter D, et al. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry. 2003 ; 64: 5-19
42. Kay SR, Opler LA, Fiszbein A Positive and Negative Syndrome Scale (PANSS). Manual. North Tonawanda, NY: Multi-Health Systems Inc ; 1992 :
43. Kumari V, Antonova E, Geyer MA, et al. A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. Int J Neuropsychopharmacol. 2007 ; 10: 463-477
44. Kumari V, Checkley SA, Gray JA. Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers. Psychopharmacology (Berl). 1996 ; 128: 54-60
45. Kumari V, Soni W, Mathew VM, et al. Prepulse inhibition of the startle response in men with schizophrenia: Effects of age of onset of illness, symptoms, and medication. Arch Gen Psychiatry. 2000 ; 57: 609-614
46. Kumari V, Soni W, Sharma T. Prepulse inhibition of the startle response in risperidone-treated patients: Comparison with typical antipsychotics. Schizophr Res. 2002 ; 55: 139-146
47. Leumann L, Feldon J, Vollenweider FX, et al. Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biol Psychiatry. 2002 ; 52: 729-739
48. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal. 1999 ; 14: 143-149
49. Ludewig K, Ludewig S, Seitz A, et al. The acoustic startle reflex and its modulation: Effects of age and gender in humans. Biol Psychol. 2003 ; 63: 311-323
50. Murphy KC. Schizophrenia and velo-cardio-facial syndrome. Lancet. 2002 ; 359: 426-430
51. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999 ; 56: 940-945
52. Niklasson L, Rasmussen P, Oskarsdottir S, et al. Neuropsychiatric disorders in the 22q11 deletion syndrome. Genet Med. 2001 ; 3: 79-84
53. Oranje B, van Oel CJ, Gispen-de Wied CC, et al. Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol. 2002 ; 22: 359-365
54. Ornitz EM Startle Modification: Implications for Neuroscience, Cognitive Science, and Clinical Science. Dawson ME Schell AM Böhmelt AH, ed. New York: Cambridge University Press ; 1999: 245-266.
55. Ornitz EM, Guthrie D, Kaplan AR, et al. Maturation of startle modulation. Psychophysiology. 1986 ; 23: 624-634
56. Ornitz EM, Guthrie D, Sadeghpour M, et al. Maturation of prestimulation-induced startle modulation in girls. Psychophysiology. 1991 ; 28: 11-20
57. Oskarsdottir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: A population-based study in Western Sweden. Arch Dis Child. 2004 ; 89: 148-151
58. Papolos DF, Faedda GL, Veit S, et al. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: Does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?. Am J Psychiatry. 1996 ; 153: 1541-1547
59. Paylor R, Glaser B, Mupo A, et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Nat Acad Sci USA. 2006 ; 103: 7729-7734
60. Paylor R, McIlwain KL, McAninch R, et al. Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments. Hum Mol Genet. 2001 ; 10: 2645-2650
61. Petrovsky N, Quednow BB, Ettinger U, et al. Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology. 2010 ; 35: 1429-1439
62. Quednow BB, Ettinger U, Mossner R, et al. The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J Neurosci. 2011 ; 31: 6684-6691
63. Quednow BB, Frommann I, Berning J, et al. Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biol Psychiatry. 2008 ; 64: 766-773
64. Quednow BB, Schmechtig A, Ettinger U, et al. Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study. Biol Psychiatry. 2009 ; 66: 614-620
65. Quednow BB, Wagner M, Mossner R, et al. Sensorimotor gating of schizophrenia patients depends on Catechol O-methyltransferase Val158Met polymorphism. Schizophr Bull. 2010 ; 36: 341-346
66. Quednow BB, Wagner M, Westheide J, et al. Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine. Biol Psychiatry. 2006 ; 59: 536-545
67. Raux G, Bumsel E, Hecketsweiler B, et al. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet. 2007 ; 16: 83-91
68. Roussos P, Giakoumaki SG, Adamaki E, et al. The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males. Biol Psychiatry. 2011 ; 69: 479-486
69. Roussos P, Giakoumaki SG, Bitsios P. A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects. Biol Psychiatry. 2009 ; 65: 1063-1070
70. Roussos P, Giakoumaki SG, Rogdaki M, et al. Prepulse inhibition of the startle reflex depends on the catechol O-methyltransferase Val158Met gene polymorphism. Psychol Med. 2008 ; 38: 1651-1658
71. Scambler PJ. The 22q11 deletion syndromes. Hum Mol Genet. 2000 ; 9: 2421-2426
72. Schellekens AF, Grootens KP, Neef C, et al. Effect of apomorphine on cognitive performance and sensorimotor gating in humans. Psychopharmacology (Berl). 2010 ; 207: 559-569
73. Schmand B, Bakker D, Saan R, et al. [The Dutch Reading Test for Adults: A measure of premorbid intelligence level]. Tijdschr Gerontol Geriatr. 1991 ; 22: 15-19
74. Sobin C, Kiley-Brabeck K, Karayiorgou M. Associations between prepulse inhibition and executive visual attention in children with the 22q11 deletion syndrome. Mol Psychiatry. 2005a ; 10: 553-562
75. Sobin C, Kiley-Brabeck K, Karayiorgou M. Lower prepulse inhibition in children with the 22q11 deletion syndrome. Am J Psychiatry. 2005b ; 162: 1090-1099
76. Stark KL, Xu B, Bagchi A, et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet. 2008 ; 40: 751-760
77. Swerdlow NR, Auerbach P, Monroe SM, et al. Men are more inhibited than women by weak prepulses. Biol Psychiatry. 1993 ; 34: 253-260
78. Swerdlow NR, Braff DL, Geyer MA. Cross-species studies of sensorimotor gating of the startle reflex. Ann N Y Acad Sci. 1999 ; 877: 202-216
79. Swerdlow NR, Geyer MA, Braff DL. Neural circuit regulation of prepulse inhibition of startle in the rat: Current knowledge and future challenges. Psychopharmacology (Berl). 2001 ; 156: 194-215
80. Swerdlow NR, Lipska BK, Weinberger DR, et al. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology (Berl). 1995 ; 122: 27-34
81. Swerdlow NR, Stephany N, Shoemaker JM, et al. Effects of amantadine and bromocriptine on startle and sensorimotor gating: Parametric studies and cross-species comparisons. Psychopharmacology (Berl). 2002 ; 164: 82-92
82. Swerdlow NR, Stephany N, Wasserman LC, et al. Amphetamine effects on prepulse inhibition across-species: Replication and parametric extension. Neuropsychopharmacology. 2003 ; 28: 640-650
83. Swillen A, Devriendt K, Legius E, et al. Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet. 1997 ; 34: 453-458
84. Swillen A, Vogels A, Devriendt K, et al. Chromosome 22q11 deletion syndrome: Update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. Am J Med Genet. 2000 ; 97: 128-135
85. Thorne GL, Dawson ME, Schell AM. Attention and prepulse inhibition: The effects of task-relevant, irrelevant, and no-task conditions. Int J Psychophysiol. 2005 ; 56: 121-128
86. Tunbridge EM, Harrison PJ, Weinberger DR. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry. 2006 ; 60: 141-151
87. Tunbridge EM, Weickert CS, Kleinman JE, et al. Catechol-o- methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex. 2007 ; 17: 1206-1212
88. Turetsky BI, Calkins ME, Light GA, et al. Neurophysiological endophenotypes of schizophrenia: The viability of selected candidate measures. Schizophr Bull. 2007 ; 33: 69-94
89. Van Beveren NJ, Krab LC, Swagemakers S, et al. Functional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndrome. PLoS One. 2012 ; 7: e33473
90. Völter C, Riedel M, Wostmann N, et al. Sensorimotor gating and D2 receptor signalling: Evidence from a molecular genetic approach. Int J Neuropsychopharmacol. 2012 ;:
91. Vorstman JA, Turetsky BI, Sijmens-Morcus ME, et al. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology. 2009 ; 34: 739-746
92. Weike AI, Bauer U, Hamm AO. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry. 2000 ; 47: 61-70
93. Williams HJ, Owen MJ, O'Donovan MC. Is COMT a susceptibility gene for schizophrenia?. Schizophr Bull. 2007 ; 33: 635-641
94. Zavitsanou K, Cranney J, Richardson R. Dopamine antagonists in the orbital prefrontal cortex reduce prepulse inhibition of the acoustic startle reflex in the rat. Pharmacol Biochem Behav. 1999 ; 63: 55-61